FBRX: the cash flow

MyFinsight

For the quarter ending 2026-03-31, FBRX had -$18,734K decrease in cash & cash equivalents over the period. -$18,808K in free cash flow.

Cash Flow	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Net loss	-22,136	-24,788	-44,587	-
Depreciation expense	19	19	17	28
Stock-based compensation expense	3,177	1,664	1,479	3,115
Net loss	-	-	-	-26,905
Accretion of debt discount on available-for-sale securities	7	-9	6	240
Prepaid expenses and other assets	3,197	2,166	1,998	-1,590
Accounts payable	3,095	4,497	558	488
Accrued liabilities	-198	3,262	3,632	1,508
Income taxes payable	-	1,037	-	-
Other liabilities	439	-	-	-
Net cash used in operating activities	-18,808	-16,466	-14,000	-20,416
Purchase of available-for-sale securities	-	0	-	-
Purchase of property and equipment	0	0	55	61
Proceeds from redemptions of short-term investments	0	0	0	36,350
Net cash provided by investing activities	0	0	-55	36,289
Proceeds from issuance of common stock and pre-funded warrants	-	0	0	75,000
Payment of issuance costs associated with financings	0	0	475	6,966
Proceeds from exercise of warrants	-	-	-	2
Proceeds from issuance of common stock upon exercise of underwriters' option	-	0	1,779	-
Proceeds from issuance of common stock under espp	101	0	9	9
Proceeds from exercise of warrants and options	-	15	19	-
Taxes paid related to net share settlement of equity awards	27	6	5	18
Settlement of fractional shares paid in cash	-	0	0	-
Net cash provided by (used in) financing activities	74	9	1,325	68,027
Net (decrease) increase in cash and cash equivalents	-18,734	-16,457	-12,730	83,900
Cash and cash equivalents beginning of period	76,957	93,414	22,244	-
Cash and cash equivalents end of period	58,223	76,957	93,414	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.